GEN Exclusives

More »

GEN News Highlights

More »
Nov 5, 2012

Bayer Buys Genomics Software from MediSapiens

  • MediSapiens will provided Bayer HealthCare Pharmaceuticals with a new cloud-computing application to analyze and visualize multidimensional genomics data. Bayer says that the software, called OncoGenomics Explorer, will provide it with centralized access to unified global genomics data for utilization across the entire research organization, from target discovery to drug repositioning.

    "Big Data is becoming increasingly important in pharmaceutical research. Until now, the lack of software tools that can be adapted to various research environments has limited the full-scale use of this enormous reservoir of available data. OncoGenomics Explorer is our answer to this demand," says Tommi Pisto, CEO of MediSapiens.

    Based on a large unified gene expression database, MediSapiens claims that its platform extends into highly tailored solutions to meet the exact needs of various demanding research environments. 

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »